4th Quarter - Report

TIBER CREEK GROUP for MERCK & CO., INC

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to drug pricing, reimbursement for prescription drugs, and the pharmaceutical supply chain. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. HR 4100/S 1712, DISARM Act; Pioneering Antimicrobial Subscriptions to End Upsurging Resistance (PASTEUR) Act; Executive Order on Lowering Drug Prices by Putting America First; H.R. 133 / PL 116-260 - FY2021 Omnibus and COVID Relief and Response Act; Issues related to the Medicaid Drug Rebate Program

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2543 (116th), H.R. 3 (116th), H.R. 4100 (116th), H.R. 133 (116th)

Medicare/Medicaid MMM

Issues relating to pharmaceutical pricing and transparency. Provisions relating to Part D Pricing Reform. Proposal to eliminate Medicaid inflationary cap. Issues relating to biosimilars coverage & pricing. S. 2543 - The Prescription Drug Price Reduction Act. H.R. 3 - Lower Drug Costs Now Act of 2019. H.R. 6800, the Health and Economic Recovery Omnibus Emergency Solutions (HEROES) Act; HR 4100/S 1712, DISARM Act

LobbyistCovered position, as disclosed
JOHN MICHAEL GONZALEZ —
JONATHON JONES —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 3 (116th), H.R. 4100 (116th), S. 2543 (116th), H.R. 6800 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.